If roflumilast inhibits the innate immunity in the stable patient, what about infection?
作者信息
Blasco Luis M
出版信息
Clin Respir J. 2013 Jan;7(1):e11-2. doi: 10.1111/j.1752-699X.2012.00288.x. Epub 2012 Mar 23.
Abstract
摘要
相似文献
1
If roflumilast inhibits the innate immunity in the stable patient, what about infection?如果罗氟司特抑制稳定期患者的固有免疫，那感染方面会怎样呢？
Clin Respir J. 2013 Jan;7(1):e11-2. doi: 10.1111/j.1752-699X.2012.00288.x. Epub 2012 Mar 23.
2
Response to commentary: 'If roflumilast inhibits the innate immunity in the stable patient, what about infection?'.对评论的回应：“如果罗氟司特抑制稳定期患者的固有免疫，那感染怎么办？”
Clin Respir J. 2013 Jul;7(3):e20-1. doi: 10.1111/crj.12019. Epub 2013 Jun 13.
3
Roflumilast (Daliresp) for COPD.罗氟司特（达力释）用于慢性阻塞性肺疾病。
Med Lett Drugs Ther. 2011 Jul 25;53(1369):59-60.
4
Roflumilast for severe COPD?罗氟司特用于重度慢性阻塞性肺疾病？
Drug Ther Bull. 2011 Apr;49(4):45-8; quiz iii-iv. doi: 10.1136/dtb.2011.02.0025.
5
Polymorphous Light Eruptions Treated With Roflumilast 0.3% Cream: A Case Report.用0.3%罗氟司特乳膏治疗多形性光疹：一例报告
J Drugs Dermatol. 2024 Aug 1;23(8):686-687. doi: 10.36849/JDD.8398.
6
Roflumilast cream (Zoryve) for atopic dermatitis.用于特应性皮炎的罗氟司特乳膏（Zoryve）。
Med Lett Drugs Ther. 2024 Sep 16;66(1711):150-151. doi: 10.58347/tml.2024.1711b.
7
No dose adjustment on coadministration of the PDE4 inhibitor roflumilast with a weak CYP3A, CYP1A2, and CYP2C19 inhibitor: an investigation using cimetidine.在与弱 CYP3A、CYP1A2 和 CYP2C19 抑制剂西咪替丁合用的情况下，无需调整 PDE4 抑制剂罗氟司特的剂量：一项使用西咪替丁的研究。
J Clin Pharmacol. 2011 Apr;51(4):594-602. doi: 10.1177/0091270010368282. Epub 2010 May 19.
8
A review of the advances in chronic obstructive pulmonary disease treatment.慢性阻塞性肺疾病治疗进展综述
J Pharm Pract. 2012 Dec;25(6):576-82. doi: 10.1177/0897190012460828. Epub 2012 Oct 16.
9
The potential role of racecadotril in the treatment of diarrhea associated with roflumilast.消旋卡多曲在治疗与罗氟司特相关的腹泻中的潜在作用。
Arch Bronconeumol. 2012 Nov;48(11):426. doi: 10.1016/j.arbres.2012.03.002. Epub 2012 May 4.
10
Roflumilast added to triple therapy in patients with severe COPD: a real life study.罗氟司特添加至重度慢性阻塞性肺疾病患者三联疗法中的真实生活研究。
Pulm Pharmacol Ther. 2015 Feb;30:16-21. doi: 10.1016/j.pupt.2014.10.002. Epub 2014 Oct 30.
引用本文的文献
1
Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations.罗氟司特用于频繁急性加重的重度慢性阻塞性肺疾病患者：肺炎住院和严重急性加重的风险
J Clin Med. 2020 May 12;9(5):1442. doi: 10.3390/jcm9051442.
Zotero 插件